Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $21.39 $26.48 Wednesday, 8th May 2024 ARWR stock ended at $25.22. This is 0.88% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 3.99% from a day low at $24.30 to a day high of $25.27.
90 days $21.39 $36.72
52 weeks $20.67 $41.28

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Dec 29, 2016 $1.53 $1.66 $1.50 $1.65 2 208 095
Dec 28, 2016 $1.52 $1.57 $1.49 $1.55 1 310 546
Dec 27, 2016 $1.59 $1.63 $1.43 $1.53 2 904 491
Dec 23, 2016 $1.38 $1.59 $1.35 $1.59 4 630 279
Dec 22, 2016 $1.27 $1.37 $1.26 $1.37 2 017 519
Dec 21, 2016 $1.22 $1.28 $1.20 $1.27 1 691 820
Dec 20, 2016 $1.27 $1.30 $1.22 $1.24 2 289 781
Dec 19, 2016 $1.24 $1.32 $1.22 $1.25 1 701 466
Dec 16, 2016 $1.29 $1.30 $1.23 $1.24 2 720 470
Dec 15, 2016 $1.35 $1.35 $1.25 $1.27 1 759 913
Dec 14, 2016 $1.28 $1.31 $1.25 $1.27 1 578 049
Dec 13, 2016 $1.26 $1.30 $1.25 $1.27 1 152 683
Dec 12, 2016 $1.35 $1.36 $1.25 $1.28 2 310 752
Dec 09, 2016 $1.39 $1.39 $1.34 $1.35 1 366 117
Dec 08, 2016 $1.36 $1.39 $1.33 $1.37 1 163 173
Dec 07, 2016 $1.38 $1.40 $1.34 $1.37 1 226 049
Dec 06, 2016 $1.41 $1.44 $1.35 $1.38 1 863 201
Dec 05, 2016 $1.40 $1.45 $1.39 $1.42 2 374 776
Dec 02, 2016 $1.40 $1.48 $1.33 $1.44 6 234 603
Dec 01, 2016 $1.50 $1.53 $1.32 $1.32 5 607 250
Nov 30, 2016 $1.69 $1.80 $1.42 $1.44 18 088 339
Nov 29, 2016 $4.46 $4.50 $4.37 $4.39 735 632
Nov 28, 2016 $4.67 $4.67 $4.41 $4.46 1 381 410
Nov 25, 2016 $4.46 $4.70 $4.40 $4.67 571 281
Nov 23, 2016 $4.49 $4.55 $4.25 $4.49 1 710 237
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT